As of February 24, 2017, 19 brokerage firms were actively tracking Albemarle (ALB) stock. About 58.0% of them have recommended a “buy” for the stock, and 42.0% have recommended a “hold.” None of them have recommended a “sell.”
Receive e-mail alerts for new research on TSLA:
Interested in TSLA?
Don’t miss the next report.
The analyst consensus for ALB indicates a 12-month target price of $99.65. That implies a return potential of 7.2% from its closing price of $92.93 on February 24, 2017.
Albemarle’s positive business developments, including acquisitions, focus on reducing interest expense. Those factors, along with the growing global demand for lithium, could be the primary drivers for analysts recommending a “buy” for the stock.
Below are the recommended target prices for Albemarle from some of the brokerage firms:
You can indirectly hold Albemarle by investing in the Global X Lithium ETF (LIT), which has invested 6.6% in Albemarle. The other top holdings of the fund include FMC (FMC), Tesla (TSLA), and Johnson Controls (JCI), with weights of 22.6%, 3.9%, and 3.5%, respectively, as of February 24, 2017.